It was also found that hOCT2 mRNA is expressed in ovarian cancer cell lines; however, its expression in clinical ovarian cancer specimens was low and did not correlate with the treatment outcome of platinum-based regimens [136]. The gene discussed is SLC22A2; the disease is ovarian carcinoma.